AMPK–SQSTM1 Dual Feedback: Mechanisms of Antioxidant Defense in Metabolic Stress

Study Background and Research Question

The tumor microenvironment is characterized by chronic metabolic and oxidative stresses, driven by factors such as nutrient depletion and reactive oxygen species (ROS) accumulation. Cancer cells adapt to these conditions through a series of metabolic and signaling changes, including the activation of the STK11/LKB1–AMPK pathway, which preserves cellular energy homeostasis and redox balance. However, the mechanistic crosstalk between these metabolic adaptation pathways and antioxidant responses, particularly under co-occurring mutations in KEAP1 and STK11/LKB1, remains incompletely understood. The central question addressed by this study is how metabolic stress orchestrates reciprocal regulation between AMPK and SQSTM1/p62 to coordinate dual activation of energy sensing and antioxidant defense mechanisms in cancer cells.

Key Innovation from the Reference Study

This investigation reveals a previously unrecognized double-positive feedback loop between AMPK and the autophagy receptor SQSTM1/p62. Under metabolic stress, this regulatory circuit enables the synergistic activation of both AMPK and the NFE2L2/NRF2 pathway, amplifying cellular antioxidant defenses. The study delineates how metabolic stress-induced phosphorylation and expression of SQSTM1/p62 is both a cause and a consequence of AMPK activation, positioning SQSTM1 as a central integrator of metabolic and oxidative stress signaling. This feedback loop clarifies molecular links between energy status, autophagic flux, and ROS detoxification, shedding light on why KEAP1 and STK11/LKB1 co-mutations frequently coexist in non-small cell lung cancer (NSCLC).

Methods and Experimental Design Insights

The authors employ a multifaceted experimental approach, integrating genetic, pharmacological, and biochemical strategies across cellular and animal models. Key methodologies include:

• Genetic manipulation of key signaling nodes (e.g., STK11/LKB1, KEAP1, SQSTM1/p62) in cancer and fibroblast cell lines to assess pathway dependencies under metabolic stress.
• Phosphorylation assays and immunoprecipitation to dissect post-translational modifications and protein-protein interactions within the feedback circuit.
• Selective inhibition of upstream regulators, including MAP3K7/TAK1, to determine their roles in SQSTM1 phosphorylation.
• Analysis of lysosomal function and pH modulation—using vacuolar ATPase inhibitors and lactic acid supplementation—to probe the impact of lysosomal deacidification on feedback loop dynamics.
• Functional readouts of antioxidant defense (e.g., NFE2L2/NRF2 target gene expression, NADPH maintenance) and tumor growth in response to pathway perturbations.

Notably, the study identifies phosphorylation sites S24 and S226 on SQSTM1 as critical for the observed feedback, using site-directed mutagenesis and functional assays to confirm their necessity.

Core Findings and Why They Matter

The central discovery is that metabolic stress induces both the expression and phosphorylation of SQSTM1/p62, establishing a double-positive feedback loop with AMPK. Mechanistically:

• AMPK Activation: Metabolic stress (e.g., glucose deprivation) activates AMPK via the canonical STK11/LKB1 pathway, supporting cellular energy homeostasis.
• SQSTM1/p62 Upregulation: Lysosomal deacidification during low glucose triggers PPP2/PP2A-dependent dephosphorylation of TFEB and TFE3, upregulating SQSTM1 expression (reference study).
• Phosphorylation by TAK1: The MAP3K7/TAK1 kinase, activated by ROS and lysosomal Ca2+ secretion, phosphorylates SQSTM1 at S24 and S226. This modification is crucial for feedback activation of both AMPK and NFE2L2/NRF2.
• Feedback Effect: The AMPK–SQSTM1 loop sustains dual activation of AMPK and antioxidant defenses (via NFE2L2/NRF2), promoting cellular adaptation and tumor survival under metabolic duress.
• Negative Regulation by Lactic Acid: Restoration of lysosomal protons (e.g., via lactic acid) abrogates the feedback loop, indicating a dependence on lysosomal pH status.

This dual feedback architecture explains why KEAP1 and STK11/LKB1 mutations frequently co-occur in NSCLC, as each arm compensates for deficits in the other, ensuring persistent antioxidant and metabolic adaptation. The findings have potential implications for targeting metabolic vulnerabilities and redox regulation in cancer and inflammation.

Comparison with Existing Internal Articles

The central findings of this study directly build upon and extend insights previously summarized in internal reviews. For example, "AMPK–SQSTM1 Feedback Loop Drives Dual Antioxidant Activation in Stress" outlines the foundational role of the AMPK–SQSTM1 feedback in cellular adaptation but does not elaborate the precise post-translational mechanisms or the involvement of TAK1 in driving SQSTM1 phosphorylation. The current study fills this mechanistic gap, providing direct evidence for the role of MAP3K7/TAK1 and specifying critical phosphorylation sites.

Further, "Strategic TAK1 Inhibition: (5Z)-7-Oxozeaenol for Antioxidant Defense" discusses the use of TAK1 inhibitors such as (5Z)-7-Oxozeaenol in dissecting the interplay between metabolic, inflammatory, and redox pathways. The new data support the rationale for employing selective TAK1 inhibition to probe the regulatory axis connecting metabolic stress sensing and antioxidant defense, especially through the lens of SQSTM1 phosphorylation. Internal summaries (example) consistently highlight the feedback loop as a critical node in tumor adaptation, now more precisely contextualized by this reference study’s mechanistic detail.

Limitations and Transferability

While the study provides compelling evidence for the AMPK–SQSTM1 double-positive feedback loop in cultured cells and selected in vivo models, several limitations merit consideration:

• Context Specificity: Most experiments are conducted in NSCLC and fibroblast models; extrapolation to other tumor types or primary tissues requires further validation.
• Mutational Landscape: The interplay between STK11/LKB1 and KEAP1 mutations, while mechanistically rationalized, may not fully account for other genetic or environmental variables influencing metabolic stress responses in heterogeneous tumors.
• Therapeutic Targeting: The dual activation circuit highlights potential vulnerabilities but also suggests redundancy; targeting one component may be compensated by the other, and combination strategies may be necessary.
• Temporal Dynamics: The feedback loop’s kinetics and reversibility under fluctuating stress conditions remain to be fully elucidated.

Transferability to inflammation research is plausible, given the shared involvement of AMPK, SQSTM1/p62, and TAK1 in both cancer and inflammatory contexts, yet direct evidence in non-tumor models is limited.

Protocol Parameters

• TAK1 Inhibition: When dissecting the role of MAP3K7/TAK1 in SQSTM1 phosphorylation, use selective TAK1 inhibitors such as (5Z)-7-Oxozeaenol at concentrations near 500 nM for 17.5 hours incubation in cell culture, as reported in the product information.
• Metabolic Stress Induction: Apply glucose deprivation or lysosomal pH modulation (e.g., via V-ATPase inhibitors) to activate the feedback loop; supplement with lactic acid to abrogate effects as a negative control.
• Genetic Manipulation: Employ siRNA or CRISPR/Cas9-mediated gene editing for STK11/LKB1, KEAP1, SQSTM1/p62 to delineate pathway dependencies.
• SQSTM1 Phosphorylation Analysis: Use phospho-specific antibodies or site-directed mutants (S24A, S226A) to evaluate functional consequences on AMPK and NFE2L2/NRF2 activation.

Research Support Resources

For researchers aiming to model or interrogate the role of TAK1 in metabolic stress signaling, (5Z)-7-Oxozeaenol (SKU B7443) is a highly selective TAK1 inhibitor with established potency and selectivity. Its use enables precise modulation of TAK1-dependent phosphorylation events, including those affecting SQSTM1/p62, and supports workflows in both cancer and inflammation research. Comprehensive handling and application guidelines are provided by APExBIO to facilitate reproducible experimental design.